Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma
Clinical trial NCT03224767 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03224767
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-05
- Primary completion
- 2023-09-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.